Free Trial

LivePerson (NASDAQ:LPSN) Shares Pass Above Two Hundred Day Moving Average - What's Next?

LivePerson logo with Computer and Technology background

Shares of LivePerson, Inc. (NASDAQ:LPSN - Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.98 and traded as high as $1.01. LivePerson shares last traded at $0.96, with a volume of 1,278,777 shares traded.

Wall Street Analysts Forecast Growth

LPSN has been the topic of several recent research reports. Wall Street Zen cut LivePerson from a "hold" rating to a "sell" rating in a research report on Wednesday, May 21st. Needham & Company LLC reiterated a "hold" rating on shares of LivePerson in a research report on Thursday, May 8th.

Get Our Latest Stock Analysis on LPSN

LivePerson Price Performance

The company has a market cap of $95.26 million, a P/E ratio of -0.47 and a beta of 1.62. The stock has a 50-day moving average of $0.86 and a 200 day moving average of $0.97.

Insider Activity at LivePerson

In related news, CEO Anthony John Sabino sold 68,088 shares of the firm's stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $0.75, for a total value of $51,066.00. Following the sale, the chief executive officer directly owned 2,852,296 shares of the company's stock, valued at $2,139,222. This trade represents a 2.33% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 2.00% of the company's stock.

Institutional Trading of LivePerson

Several large investors have recently bought and sold shares of LPSN. Two Sigma Advisers LP boosted its stake in LivePerson by 42.0% in the fourth quarter. Two Sigma Advisers LP now owns 906,027 shares of the technology company's stock valued at $1,377,000 after buying an additional 267,827 shares in the last quarter. Bridgeway Capital Management LLC acquired a new stake in LivePerson in the fourth quarter valued at about $152,000. Point72 Asia Singapore Pte. Ltd. boosted its stake in LivePerson by 146.1% in the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 73,794 shares of the technology company's stock valued at $112,000 after buying an additional 43,804 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in LivePerson in the fourth quarter valued at about $66,000. Finally, Marshall Wace LLP acquired a new stake in shares of LivePerson during the fourth quarter valued at about $57,000. 79.83% of the stock is owned by institutional investors and hedge funds.

LivePerson Company Profile

(Get Free Report)

LivePerson, Inc engages in conversational artificial intelligence. It enables brands to leverage the Conversational Cloud's intelligence engine to connect with consumers through an integrated suite of mobile and online business messaging technologies. The company offers the Conversational Cloud, an enterprise-class digital customer conversation platform, which enables businesses and consumers to connect through conversational channels, such as voice, in-app, and mobile messaging.

Recommended Stories

Should You Invest $1,000 in LivePerson Right Now?

Before you consider LivePerson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LivePerson wasn't on the list.

While LivePerson currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines